Abstract
It is well known that the central cholinergic system is intimately related to the modulation of learning (acquisition) and memory processes (retention and retrieval) in humans and animals (Haroutunian et al., 1985). Actually, there are many reports about the ameliorating effects of cholinergic drugs on memory impairment induced by transient cerebral ischemia (Yamamoto et al., 1987), electroshock (Sakurai et al., 1989) or anticholinergic drug administration (Yamamoto and Shimizu., 1987). On the other hand, it has been reported that classic H1 antagonists such as diphenhydramine, pyrilamine and promethazine provided potent depressant actions on the central nervous system (CNS) in many different situations including learning and memory (Winter and Flataker, 1951). Kamei et al. (1981a) demonstrated that diphenhydramine and promethazine induced not only a drowsy pattern in EEGs characterized by high voltage and slow waves but also an inhibition of the EEG arousal response induced by electrical stimulation of the midbrain reticular formation. Tasaka et al. (1985) reported that diphenhydramine, pyrilamine and promethazine caused a potent suppression of the two-way conditioned avoidance response (retardation of memory retrieval) in rats. In connection with this, de Almeida and Izquierdo (1988) found that immediate posttraining after intracerebroventricular (i.c.v.) administration of histamine at doses of 1 and 10 ng facilitated retention performance of step-down inhibitory avoidance behavior (passive avoidance response) measured 24hr after drug administration in rats. In addition, this histamine-induced effect was inhibited by the simultaneous administration of promethazine (1000 ng) and cimetidine (1000 ng), indicating that histamine-induced facilitation of memory retention is mediated via both H1 and H2 receptors. Bhattacharya (1990) also reported that histamine at doses of 1, 5 and 10 μ g produced a dose related dual effect on learning acquisition and retention of memory, with the lower two doses facilitating and high dose retarding the memory paradigms. In these two studies, however, normal animals were used for estimating the drug effect. This chapter provides information about the role of histamine on learning and memory not only in normal but also in some amnesic animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ader, R., Weijnen, J.A.W.M. and Moleman, P.: Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychon. Sci., 26, 125–128 (1972)
Ahn, H.-S. and Barnett, A.: Selective displacement of [3H] mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine. European J. Pharmacol., 127, 153–155 (1986)
Alvarez, E.O. and Banzán, A.M.: Histamine in dorsal and ventral hippocampus. II. Effects of H1 and H2 histamine antagonists on exploratory behavior in male rats. Physiol. Behav., 37, 39–45 (1986)
Arrang, J.-M., Garbarg, M. and Schwartz, J.-C.: Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature, 302, 832–837 (1983)
Arrang, J.-M., Garbarg, M., Lancelot, J.-C., Lecomte, J.-M., Pollard, H., Robba, M., Schunack, W. and Schwartz, J.-C.: Highly potent and selective ligands for histamine H3-receptors. Nature, 327, 117–123 (1987)
Asdourian, D., Dark, J.G., Chiodo, L. and Papich, P.S.: Active avoidance in rats with unilateral hypothalamic and optic nerve lesions. Physiol. Behav., 19, 209–211 (1977)
Bhattacharya, S.K.: Central histamine receptors in learning and memory in rats. European J. Pharmacol., 183, 295 (1990)
Burešová, O., Bureš, J., Fifková, E., Vinogradova, O. and Weiss, T.: Functional significance of corticohippocampal connections. Exp. Neurol., 6, 161–172 (1962)
Cacabelos, R. and Alvarez, X.A.: Histidine decarboxylase inhibition induced by α-fluoro- methylhistidine provokes learning-related hypokinetic activity. Agents Actions, 33, 131–134 (1991)
Coyle, J.T., Price, D.L. and DeLong, M.R.: Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science, 212, 1184–1190 (1983)
de Almeida, M.A.M.R. and Izquierdo, I.: Intracerebroventricular histamine, but not 48/80, causes posttraining memory facilitation in the rat. Arch. int. Pharmacodyn., 291, 202–207 (1988)
de Groot, J.: The rat forebrain in stereotaxic coordinates. Verh. K. Ned. Akad. Wet. Natuurkund., 52, 1–40 (1959)
Devlin, J.P. and Hargrave, K.D.: Pulmonary and antiallergic drugs: Design and synthesis. In: Devlin, J.P. (ed) Pulmonary and Antiallergic Drugs. John Wiley & Sons, New York, pp.191–316, 1985
Durant, G.J., Duncan, W.A.M., Ganellin, C.R., Parsons, M.E., Blakemore, R.C. and Rasmussen, A.C.: Impromidine (SK & F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature, 276, 403–405 (1978)
Egashira, T., Murayama, F., Kimba, Y. and Yamanaka, Y.: Age-related decrements of cholinergic markers in aged rat brain. Japan. J. Pharmacol., 52 (suppl), 74P (1990)
Feldberg, W. and Sherwood, S.L.: Injections of drugs into the lateral ventricle of the cat. J. Physiol., 123, 148–167 (1954)
Ganellin, C.R.: Chemistry and structure-activity relationships of drugs acting at histamine receptors. In: Ganellin C.R. and Parsons, M.E. (ed) Pharmacology of Histamine Receptors. Wright-PSG, Bristol, pp. 10–102, 1982
Garbarg, M., Barbin, G., Bischoff, S., Pollard, H. and Schwartz, J.C.: Dual localization of histamine in an ascending neuronal pathway and in non-neuronal cells evidenced by lesions in the lateral hypothalamic area. Brain Res., 106, 333–348 (1976)
Garbarg, M., Barbin, G., Rodergas, E. and Schwartz, J.C.: Inhibition of histamine synthesis in brain by α-fluoromethylhistidine, a new irreversible inhibitor: In vitro and in vivo studies. J. Neurochem., 35, 1045–1052 (1980)
Grossman, S.P.: Avoidance behavior and aggression in rats with transections of the lateral connections of the medial or lateral hypothalamus. Physiol. Behav., 5, 1103–1108 (1970)
Haas, H.L.: Histamine potentiates neuronal excitation by blocking a calcium-dependent potassium conductance. Agents Actions, 14, 534–537 (1984)
Haroutunian, V., Barnes, E. and Davis, K.L.: Cholinergic modulation of memory in rats. Psychopharmacology, 87, 266–271 (1985)
Inami, T., Tanaka, T., Sakurai, M. and Hayashi, S.: Learning impairment in aged, spontaneously hypertensive rats. Japan. J. Pharmacol., 52 (suppl), 355P (1990)
Ikeda, Y. and Matsushita, K.: The learning, memory and drug effects in aged rats In: Tadokoro, S. (ed) Investigation of Antidementia Drug. Animal Experiments of Learning and Memory, (in Japanese), Seiwa Shoten, Pub. Tokyo, pp. 108–120, 1985
Ishikawa, A., Ikeda, Y., Takato, M., Matsushita, H. and Hata, S.: The light-dark discriminative learning of aged rats. A comparison of the positive and negative reinforcement. Eighth International Congress of Pharmacology, p. 626, 1981
Isaacson, R.L., Douglas, R.J. and Moore, R.Y.: The effect of radical hippocampal ablation on acquisition of avoidance response. J. Comp. Physiol. Psychol., 54, 625–628 (1961)
Kakihana, M., Yamazaki, N. and Nagaoka, A.: Effects of idebenone (CV-2619) on the concentrations of acetylcholine and choline in various brain regions of rats with cerebral ischemia. Japan. J. Pharmacol., 36, 357–363 (1984)
Kamei, C., Kiniwa, S., Ikegami, N. and Tasaka, K.: Effect of 4-(p-chlorobenzyl)-2-[N- methylperhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine) on EEGs and behavior ir rats. Jpn. J. Clin. Pharmacol. Ther., 12, 297–310 (1981a)
Kamei, C., Chung, Y.H., Dabasaki, T. and Tasaka, K.: Species differences elicited by intraventricular injection of histamine on EEGs and behavior. Japan. J. Pharmacol., 31 (suppl), 86P (1981b)
Kamei, C., Dabasaki, T. and Tasaka, K.: Cataleptic effect of histamine induced by intraventric ular injection in mice. Japan. J. Pharmacol., 33, 1081–1084 (1983)
Kamei, C., Dabasaki, T. and Tasaka, K.: Effect of intraventricular injection of histamine on the pinna reflex in mice. Japan. J. Pharmacol., 35, 193–195 (1984)
Kamei, C., Akahori, H. and Tasaka, K.: Influence of histamine and related compounds on the hypnotic effect of thiopental in mice. J. Pharmacobio-Dyn., 9, 112–116 (1986)
Kamei, C., Tsujimoto, S. and Tasaka, K.: Effects of cholinergic drugs and cerebral metabolic activators on memory impairment in old rats. J. Pharmacobio-Dyn., 13, 772–777 (1990a)
Kamei, C., Chung, Y.H. and Tasaka, K.: Influence of certain H1-blockers on the step- through active avoidance response in rats. Psychopharmacology, 102, 312–318 (1990b)
Kamei, C. and Tasaka, K.: Participation of histamine in the step-through active avoidance response aid its inhibition by H1-blockers. Japan. J. Pharmacol., 57, 473–482 (1991)
Kamei, C. and Tasaka, K.: Effect of intracerebroventricular injection of histamine on memory impairment induced by hippocampal lesions in rats. Japan. J. Pharmacol., 58 (suppl), 55P (1992)
Kamei, C., Okumura, Y. and Tasaka, K.: Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology, 111, 376–382 (1993a)
Kamei, C. and Tasaka, K.: Effect of histamine on memory retrieval in old rats. Biol. Pharm. Bull., 16, 128–132 (1993b)
Kaneko, T., Kitahara, A., Ozaki, S., Takizawa, K. and Yamatsu, K.: Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system. Arzneim.-Forsch., 31, 1206–1212 (1981)
Kollonitsch, J., Patchett, A.A., Marburg, S., Maycock, A.L., Perkins, L.M., Doldouras, G.A., Duggan, D.E. and Aster, S.D.: Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature, 274, 906–908 (1978)
Laduron, P.M., Janssen, P.F.M., Gommeren, W. and Leysen, J.E.: In vitro and in vivo binding characteristics of a new long-acting histamine H1-antagonist, astemizole. In: Astemizole: a new, non-sedative, long-acting H1-antagonist. The Medicine Publishing Foundation, Symposium Series 11, Oxford, pp. 11–23, 1983
Lippa, A.S., Pelham, R.W., Beer, B., Critchett, D.J., Dean, R.L. and Bartus, R.T.: Brain cholinergic dysfunction and memory in aged rats. Neurobiol. Aging, 1, 13–19 (1980)
Maeyama, K., Watanabe, T., Yamatodani, A., Taguchi, Y., Kambe, H. and Wada, H.: Effect of α-fluoromethylhistidine on the histamine content of the brain of W/Wv mice devoid of mast cells: turnover of brain histamine. J. Neurochem., 41, 128–134 (1983)
Martin, U. and Römer, D.: The pharmacological properties of a new, orally active antianaphylactic Compound: ketotifen, a benzocycloheptathiophene. Arzneim.-Forsch., 28, 770–782 (1978)
McNew, J.J. and Thompson, R.: Role of the limbic system in active and passive avoidance conditioning in the rat. J. Comp. Physiol. Psychol., 61, 173–180 (1966)
Monti, J.M., D’Angelo, L., Jantos, H. and Pazos, S.: Effects of α-fluoromethylhistidine on sleep and wakefulness in the rat. J. Neural. Transm., 72, 141–145 (1988)
Muñoz, C. and Grossman, S.P.: Some behavioral effects of selective neuronal depletion by kainic acid in the dorsal hippocampus of rats. Physiol. Behav., 25, 581–587 (1980)
Nakagawa, Y., Yamazaki, A., Ishima, T., Tamura, M., Ogasawara, T., Ukai, Y. and Kimura, K.: Age-related changes in learning abilities in Fischer 344 rats. Japan. J. Pharmacol, 49 (suppl), 267P (1989)
Nakahiro, M., Fujita, N., Fukuchi, I., Saito, K., Nishimura, T. and Yoshida, H.: Pantoyl-γ-aminobutyric acid facilitates cholinergic function in the central nervous system. J. Pharmacol. Exp. Ther., 232, 501–506 (1985)
Ohmori, K., Ishii, H., Shuto, K. and Nakamizo, N.: Pharmacological studies on oxatomide: (5) Effect on the central and peripheral nervous systems. Folia pharmacol. japon., 81, 245–266 (1983a)
Ohmori, K., Ishii, H., Nito, M., Shuto, K. and Nakamizo, N.: Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators. Folia pharmacol. japon., 81, 399–409 (1983b)
Ohmori, K., Ishii, H. and Ishii, A.: Pharmacological studies on oxatomide (10) Antiallergic effects of oxatomide and other antiallergic drugs. Clin. Report, 21, 4045–4052 (1987)
Oishi, R., Itoh, Y., Nishibori, M. and Saeki, K.: Effects of the histamine H3-agonist (R)-α- methylhistamine and the antagonist thioperamide on histamine metabolism in the mouse and rat brain. J. Neurochem., 52, 1388–1392 (1989)
Oka, M. and Shimizu, M.: A simple avoidance procedure for testing psychotropic drugs in mice. Japan. J. Pharmacol., 25, 121–127 (1975)
Onodera, K., Yamatodani, A. and Watanabe, T.: Effects of α-fluoromethylhistidine on locomotor activity, brain histamine and catecholamine contents in rats. Meth. Find. Exp. Clin. Pharmacol., 14, 97–105 (1992)
Panula, P., Yang, H.-Y.T. and Costa, E.: Histamine-containing neurons in the rat hypothalamus. Proc. Nati. Acad. Sci. U.S.A., 81, 2572–2576 (1984)
Papsdorf, J.D. and Woodruff, M.: Effects of bilateral hippocampectomy on the rabbit’s acquisition of shuttle-box and passive-avoidance responses. J. Comp. Physiol. Psychol., 73, 486–489 (1970)
Paxinos, G. and Watson, C.: The rat brain in stereotaxic coordinates. Academic Press. San Diego, 1986
Perry, E.K., Blessed, K.G., Tomlinson, B.E., Perry, R.H., Crow, T.J., Cross, A.J., Dockray, G.T., Dimaline, R. and Arregui, A.: Neurochemical activities in human temporal lobe related to aging and Alzheimer’s type changes. Neurobiol. Aging, 2, 251–256 (1981)
Reuse, J.J.: Comparisons of various histamine antagonists. Br. J. Pharmacol., 3, 174–180 (1948)
Rich, I. and Thompson, R.: Role of the hippocampo-septal system, thalamus, and hypothalamus in avoidance conditioning. J. Comp. Physiol. Psychol., 59, 66–72 (1965)
Rigter, H., van Riezen, H. and de Wied, D.: The effects of ACTH- and vasopressin- analogues on CO2-induced retrograde amnesia in rats. Physiol. Behav., 13, 381–388 (1974)
Rüthrich, H.-L., Wetzel, W. and Matthies, H.: Memory retention in old rats: Improvement by orotic acid. In: Marsan, C.A. and Matthies, H. (ed) Neuronal Plasticity and Memory Formation. Raven Press, New York, pp. 227–230, 1982.
Sakai, N., Onodera, K., Maeyama, K., Yanai, K. and Watanabe, T.: Effects of (S)-α- fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice. Life Sci., 51, 397–405 (1992)
Sakurai, E., Niwa, H., Yamasaki, S., Maeyama, K. and Watanabe, T.: The disposition of a histidine decarboxylase inhibitor (S)-α-fluoromethylhistidine in rats. J. Pharm. Pharmacol., 42, 857–860 (1990)
Sakurai, T., Ojima, H., Yamasaki, T., Kojima, H. and Akashi, A.: Effects of N-(2,6-di- methylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats. Japan. J. Pharmacol., 50, 47–53 (1989)
Schild, H.O.: pA, a new scale for the measurement of drug antagonism. Br. J. Pharmacol., 2, 189–206 (1947)
Schwartz, J.C., Lampart, C. and Rose, C.: Histamine formation in rat brain in vivo: Effects of histidine loads. J. Neurochem., 19, 801–810 (1972)
Shibata, K., Hirano, Y., Fujino, A., Shimazu, M., Nagakawa, N., Inoue, K. and Uemura, I.: Metabolic fate of 14C-oxatomide in rats. Jpn. Pharmacol. Ther., 12, 3887–3903 (1984)
Soda, Y., Mori, I., Yokoyama, N., Horisaka, K., Shichino, F., Shimada, A., Murai, K. and Ito, N.: Metabolic fate of mequitazine (LM-209) (1) Absorption, distribution and excretion of LM-209 in rats. Iyakuhin Kenkyu, 12, 462–480 (1981)
Sunami, A. and Tasaka, K.: Two aspects of the excitatory influence of histamine on hippocampal neurons in guinea pigs. Meth. Find. Exp. Clin. Pharmacol., 13, 85–91 (1991)
Tagami, H., Sunami, A., Akagi, M. and Tasaka, K.: Effect of histamine on the hippocampal neurons in guinea-pigs. Agents Actions, 14, 538–542 (1984)
Tanaka, S., Shirasaki, Y., Yamada, F., Endo, W. and Ashida, S.: Impairment effect of DM-9384, a new cognition enhancer, on learning deficits in cerebral embolized rats. Japan. J. Pharmacol., 52 (suppl), 74P (1990)
Tasaka, K., Kamei, C., Akahori, H. and Kitazumi, K.: The effects of histamine and some related compounds on conditioned avoidance response in rats. Life Sci., 37, 2005–2014 (1985)
Tasaka, K., Kamei, C., Katayama, S., Kitazumi, K., Akahori, H. and Hokonohara, T.: Comparative study of various H1-blockers on neuropharmacological and behavioral effects including 1-(2-ethoxyethyl)-2-(4-methyl-l-homopiperazinyl)benzimidazole difumarate (KB- 2413), a new antiallergic agent. Arch. int. Pharmacodyn., 280, 275–291 (1986)
Tasaka, K.: Anti-allergic drugs. Drugs of Today, 22, 101–133 (1986)
Tasaka, K., Kamei, C., Chung, Y.H. and Nakano, S.: Pharmacological effects of oxitropium bromide on the central nervous system. Pharmacometrics, 36, 425–432 (1988)
Tasaka, K., Chung, Y.H., Sawada, K. and Mio, M.: Excitatory effect of histamine on the arousal system and its inhibition by H1 blockers. Brain Res. Bull., 22, 271–275 (1989a)
Tasaka, K., Kamei, C., Nakano, S., Tsujimoto, S. and Chung, Y.H.: Effect of epinastine, a new antiallergic agent, on the central nervous system. Pharmacometrics, 38, 53–62 (1989b)
Tasaka, K., Kamei, C., Tsujimoto, S., Yoshida, T. and Aoki, I.: Central effect of the potent long-acting H1-antihistamine levocabastine. Arzneim.-Forsch., 40, 1295–1299 (1990)
Tatsumi, K., Ou, T., Yamada, H. and Yoshimura, H.: Studies on metabolic fate of a new antiallergic agent, azelastine (4-(p-chlorobenzyl)-2- [N-methylperhydroazepinyl-(4)] -1- (2H)-phthalazinone hydrochloride). Japan. J. Pharmacol., 30, 37–48 (1980)
Uzan, A., Le Fur, G. and Malgouris, C.: Are antihistamines sedative via a blockade of brain H1 receptors? J. Pharm. Pharmacol., 31, 701–702 (1979)
Van den Brink, F.G. and Lien, E.J.: Competitive and noncompetitive antagonism. In: Rocha e Silva, M. (ed) Histamine II and Anti-Histaminics, Springer-Verlag, Berlin, pp. 333–367, 1978
Wallace, J.E., Krauter, E.E. and Campbell, B.A.: Motor and reflexive behavior in the aging rat. J. Gerontol., 35, 364–370 (1980)
Wauquier, A., Van den Broeck, W.A.E., Awouters, F. and Janssen, P.A.J.: A comparison between astemizole and other antihistamines on sleep-wakefulness cycles in dogs. Neuropharmacology, 20, 853–859 (1981)
Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T. and DeLong, M. R.: Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 1237–1239 (1982)
Winter, C.A. and Flataker, L.: The effect of antihistaminic drugs upon the performance of trained rats. J. Pharmacol. Exp. Ther., 101, 156–162 (1951)
Wyngaarden, J.B. and Seevers, M.H.: The toxic effects of antihistaminic drugs. J. Amer. Med. Ass., 145, 277–282 (1951)
Yamatodani, A. and Watanabe, T.: Studies with α-fluoromethylhistidine as a probe. In: Watanabe, T. and Wada, H. (ed) Histaminergic Neurons: Morphology and Function. CRC Press, Boca Raton, pp. 231–240, 1991
Yamamoto, M., Shimizu, M., Sakamoto, N., Ohtomo, H. and Kogure, K.: Protective effects of indeloxazine hydrochloride on cerebral ischemia in animals. Arch. int. Pharmacodyn., 290, 16–24 (1987)
Yamamoto, M. and Shimizu, M.: Cerebral activating properties of indeloxazine hydrochloride. Neuropharmacology, 26, 761–770 (1987)
Yamazaki, N., Take, Y., Nagaoka, A. and Nagawa, Y.: Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in rats. Japan. J. Pharmacol., 36, 349–356 (1984)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Tasaka, K. (1994). The role of histamine on learning and memory. In: New Advances in Histamine Research. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68263-9_2
Download citation
DOI: https://doi.org/10.1007/978-4-431-68263-9_2
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68265-3
Online ISBN: 978-4-431-68263-9
eBook Packages: Springer Book Archive